Tesamorelin: The Peptide Revolutionizing Visceral Fat Loss and Metabolic Health
Tesamorelin is no longer just a niche therapy for HIV-related lipodystrophy. Backed by robust clinical trials, this GHRH analog is now emerging as a powerful tool for reducing visceral fat, optimizing IGF-1, and restoring metabolic balance in aging, insulin resistance, and fatty liver disease.
